https://www.npr.org/sections/shots-health-news/2025/10/29/nx-s1-5575561/alzheimers-pill-apoe4-high-risk-lecanemab-donanemab
0
0
10/29/25 at 10:00am
Organization
NPR
45 words
0
Comments
A new study is reviving hope that a twice-daily pill can slow down Alzheimer's in people whose genes put them at high risk for the disease.
You are the first to view
Create an account
or login to join the discussion